Andrew Paine

Stock Analyst at CLSA

(0.43)
# 3,924
Out of 4,827 analysts
3
Total ratings
33.33%
Success rate
-11.2%
Average return
Main Sectors:

Stocks Rated by Andrew Paine

ResMed
Jan 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $244.70
Upside: -